Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01459692|
Recruitment Status : Completed
First Posted : October 26, 2011
Last Update Posted : May 7, 2018
|Condition or disease||Intervention/treatment||Phase|
|Seizures Epilepsy||Other: Music Exposure||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps|
|Study Start Date :||February 2005|
|Actual Primary Completion Date :||January 2008|
|Actual Study Completion Date :||January 2008|
No Intervention: Control group - No Music Exposure
Subjects that were assigned to the control group of the study were not exposed to music.
Experimental: Music Exposure
The treatment subjects were randomly assigned to receive nightly exposure to music at periodic intervals between the hours of 9:00 PM and 8:00 AM.
Other: Music Exposure
Twenty-seven subjects were randomly assigned to receive nightly exposure to music at periodic intervals between the hours of 9:00 PM and 8:00 AM.
- Changes in seizure rates [ Time Frame: 3 years ]Main Outcome Measure: The effect of exposure to the auditory stimulus on seizure frequency. Changes in seizure rates from baseline to treatment years were determined and statistically compared within the treatment and control groups, as well as between the groups to assess efficacy of treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01459692
|United States, South Carolina|
|Medical University of South Carolina|
|Charleston, South Carolina, United States, 29412|
|Principal Investigator:||Robert P Turner, MD, MSCR||Medical University of South Carolina|
|Principal Investigator:||Mark Bodner, Ph.D.||MIND Research Institute|